← SynDRA
LINRODOSTAT
SynDRA canonical compound SYN0039695 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
IDO1
Mechanism of action
indoleamine 2,3-dioxygenase inhibitor
All known targets
IDO1
Mechanisms of action (all sources)
IDO1 INHIBITOR
Indoleamine 2,3-dioxygenase inhibitor
Cross-references
PubChem CID:
121328278
ChEMBL:
CHEMBL4297598
KEGG:
D11412
TTD: D0DP5I
Synonyms
BMS-986205
F-001287
F001287
ONO-7701
ONO7701
KRTIYQIPSAGSBP-KLAILNCOSA-N
BMS986205
UNII-0A7729F42K
0A7729F42K
GTPL9707
SCHEMBL18826792
SCHEMBL17740982
SCHEMBL19105151
EX-A2606
AKOS032954040
HY-101560
CS-0021719
Q29213697
(R)-N-(4-chlorophenyl)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide
(2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide
(2R)-N-(4-Chlorophenyl)-2-(4-(6-fluoro-4-quinolyl)cyclohexyl)propanamide, cis
Cyclohexaneacetamide, N-(4-chlorophenyl)-4-(6-fluoro-4-quinolinyl)-alpha-methyl-, cis-(alphaR)-
RefChem:905831
BMS 986205
ONO 7701
F 001287
C24H24ClFN2O
LINRODOSTAT [INN]
Linrodostat (USAN/INN)
LINRODOSTAT [WHO-DD]
BMS-986205(Linrodostat)
Linrodostat(BMS-986205)
orb1302780
BMS-986205(Linrodostat)?
Linrodostat (BMS-986205)
SCHEMBL29354801
SCHEMBL29437358
GLXC-10909
BDBM50285416
Look up LINRODOSTAT in the interactive SynDRA portal →